Dr. Johnson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3601 21st Ave S
Nashville, TN 37232Phone+1 615-322-3000
Education & Training
- Duke University HospitalResidency, 2008 - 2011
- University of Alabama School of MedicineClass of 2008
Certifications & Licensure
- TN State Medical License 2012 - 2026
- AL State Medical License 2020 - 2020
- NC State Medical License 2008 - 2011
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Genomic mediators of acquired resistance to immunotherapy in metastatic melanoma.Julia Schiantarelli, Mouadh Benamar, Jihye Park, Haley E Sax, Giacomo Oliveira
Cancer Cell. 2025-02-10 - Immune checkpoint inhibitor infusion times and clinical outcomes in patients with melanoma.Kylie Fletcher, Saba Rehman, Rebecca Irlmeier, Fei Ye, Douglas Johnson
The Oncologist. 2025-01-17 - Steroid-refractory immune mediated hepatitis managed with budesonide in patients with metastatic melanoma: proof of concept and literature review.Roma A Kankaria, Douglas B Johnson
The Oncologist. 2025-01-17
Press Mentions
- Eleven Vanderbilt Scientists Among World’s “Highly Cited” ResearchersNovember 19th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: